Ilya M. Rachman - 11 Jun 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CEO and Chairman, Director
Signature
/s/ Ilya Rachman
Issuer symbol
IMMX
Transactions as of
11 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 17:45:13 UTC
Previous filing
10 Jun 2024
Next filing
20 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 1,136,259 11 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +340,000 $0.000000 340,000 11 Jun 2024 Common Stock 340,000 $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.